60 Degrees Pharmaceuticals Inc (SXTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 529 | 308 | 256 | 272 | 148 |
| Cost of Goods | 538 | 50 | 73 | 118 | 112 |
| Gross Profit | -9 | 258 | 183 | 154 | 36 |
| Operating Expenses | 2,854 | 1,913 | 2,167 | 2,337 | 2,267 |
| Operating Income | -2,326 | -1,605 | -1,911 | -2,065 | -2,119 |
| Interest Expense | 2 | 1 | 2 | 1 | 2 |
| Other Income | 10 | -127 | 36 | 17 | -40 |
| Pre-tax Income | -2,317 | -1,733 | -1,877 | -2,049 | -2,160 |
| Income Tax | 0 | 2 | 0 | -1 | 0 |
| Net Income Continuous | -2,317 | -1,735 | -1,877 | -2,049 | -2,161 |
| Minority Interests | -1 | -1 | 1 | -9 | -1 |
| Net Income | $-2,316 | $-1,734 | $-1,878 | $-2,040 | $-2,160 |
| EPS Basic Total Ops | -0.66 | -1.25 | -1.56 | 5.39 | -4.65 |
| EPS Basic Continuous Ops | -0.63 | -1.18 | -1.46 | 4.96 | -4.42 |
| EPS Diluted Total Ops | -0.66 | -1.25 | -1.56 | 5.39 | -4.65 |
| EPS Diluted Continuous Ops | -0.63 | -1.18 | -1.46 | 4.96 | -4.42 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -1.25 | -1.56 | N/A | -4.65 |
| EBITDA(a) | $-2,259 | $-1,541 | $-1,850 | $-2,005 | $-1,450 |